HUTCHMED (China) (HCM) Accounts Payables (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Accounts Payables of $33.6 million for Q2 2026, down 23.05% year-over-year from $43.7 million in Q2 2025, and up 474.71% quarter-over-quarter from $5.9 million in Q4 2025.
HUTCHMED (China) (HCM) Accounts Payables (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Accounts Payables for 12 consecutive years, with $33.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accounts Payables fell 23.05% year-over-year to $33.6 million; the TTM figure through Jun 2026 stood at $33.6 million (down 23.05% YoY), while the FY2025 annual figure was $5.9 million, up 7.43% from the prior year.
- Accounts Payables advanced to $33.6 million in Q2 2026 per HCM's latest filing, from $5.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $4.6 billion in Q4 2023 and bottomed at $5.5 million in Q4 2024.
- Historically, Accounts Payables has averaged $544.0 million across 5 years, with a median of $43.4 million in 2024.
- Annual changes were most pronounced in 2023 — Accounts Payables surged 51038.93% — and 2024, when it tumbled 99.88%.
- HUTCHMED (China)'s Accounts Payables stood at $9.1 million in 2022, then soared by 51038.93% to $4.6 billion in 2023, then sank by 99.88% to $5.5 million in 2024, then increased by 7.04% to $5.9 million in 2025, then soared by 474.71% to $33.6 million in 2026.
- Business Quant data shows HCM's Accounts Payables at $33.6 million in Q2 2026, $5.9 million in Q4 2025, and $43.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | 33.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.65 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Jun 30, 2025 | 43.73 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Jun 30, 2024 | 43.40 Mn |
| Dec 31, 2023 | 4.65 Bn |
| Jun 30, 2023 | 54.58 Mn |
| Dec 31, 2022 | 9.09 Mn |
| Jun 30, 2022 | 51.01 Mn |
| Dec 31, 2021 | 5.29 Mn |
| Jun 30, 2021 | 28.51 Mn |
| Mar 31, 2021 | 28.64 Mn |
| Jun 30, 2020 | 25.87 Mn |
| Sep 30, 2019 | 23.03 Mn |
| Jun 30, 2019 | 26.15 Mn |
| Mar 31, 2019 | 30.76 Mn |
| Dec 31, 2018 | 25.63 Mn |
| Jun 30, 2018 | 19.31 Mn |
| Dec 31, 2017 | 24.37 Mn |
| Jun 30, 2017 | 27.26 Mn |